NASCSA News

Optional page description text area...

Header Content Region

Insert text, image or banner ads here, or just delete this text and leave this area blank!

portfolio1 portfolio2 portfolio3 portfolio4

Heading 1

This is an example of the content for a specific image in the Nivo slider. Provide a short description of the image here....

Heading 2

This is an example of the content for a specific image in the Nivo slider. Provide a short description of the image here....

Heading 3

This is an example of the content for a specific image in the Nivo slider. Provide a short description of the image here....

Heading 4

This is an example of the content for a specific image in the Nivo slider. Provide a short description of the image here....

get in touch



 

View articles in News Archive

Friday - February 23, 2018 10:09 am
Center for Substance Abuse Research Continue reading →
NASCSA Testifies Before FDA
Monday - February 5, 2018 9:09 pm     A+ | a-


Link to NASCSA testimony:
http://www.nascsa.org/news/NASCSA_TestimonyFDA1.30.2018.pdf

Link to webinar:
https://www.fda.gov/newsevents/meetingsconferencesworkshops/ucm583543.htm

January 30, 2018

NASCSA testifies before FDA, Opioid Policy Steering Committee - NASCSA Statement for the Record as presented by Barbara Carter

Mr. Chair and Committee Members, the National Association of State Controlled Substances Authorities appreciates the opportunity to share with the Committee the work that our organization, states and other stakeholders are executing in partnership to address the opioid crisis. We commend the FDA and its a hearing to receive stakeholder input on how the FDA might under its authority, improve the safe use of opioid analgesics by curbing overprescribing to decrease the occurrence of new addictions and limit misuse and abuse of opioid analgesics.

To view complete testimony - Click link at top of this page

 

slide up button
NASCSA - Copyright 2012 - All Rights Reserved